Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008
| Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008 |
| Edizione | [Emergency update.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, Stop TB Department, c2008 |
| Descrizione fisica | 1 online resource (270 p.) |
| Disciplina | 615.58 |
| Altri autori (Persone) | JaramilloErnesto |
| Soggetto topico |
Antitubercular agents
Comorbidity - Treatment Highly active antiretroviral therapy HIV infections - Chemotherapy Multidrug-resistant tuberculosis - Chemotherapy Multidrug-resistant tuberculosis - Prevention |
| ISBN |
1-282-05799-5
9786612057991 92-4-068353-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER |
| Record Nr. | UNISA-996320228203316 |
| Geneva, : World Health Organization, Stop TB Department, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008
| Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008 |
| Edizione | [Emergency update.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, Stop TB Department, c2008 |
| Descrizione fisica | 1 online resource (270 p.) |
| Disciplina | 615.58 |
| Altri autori (Persone) | JaramilloErnesto |
| Soggetto topico |
Antitubercular agents
Comorbidity - Treatment Highly active antiretroviral therapy HIV infections - Chemotherapy Multidrug-resistant tuberculosis - Chemotherapy Multidrug-resistant tuberculosis - Prevention |
| ISBN |
1-282-05799-5
9786612057991 92-4-068353-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER |
| Record Nr. | UNINA-9910145965203321 |
| Geneva, : World Health Organization, Stop TB Department, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
